Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Breathing zone pollutant levels are associated with asthma exacerbations in high-risk children

Camille M. Moore, Jonathan Thornburg, Elizabeth A. Secor, Katharine L. Hamlington, Allison M. Schiltz, Kristy L. Freeman, Jamie L. Everman, Tasha E. Fingerlin, Andrew H. Liu, Max A. Seibold
doi: https://doi.org/10.1101/2023.09.22.23295971
Camille M. Moore
aCenter for Genes, Environment, and Health, National Jewish Health, Denver, CO
bDepartment of Biostatistics and Informatics, University of Colorado-AMC, Aurora, CO
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: mooreca{at}njhealth.org
Jonathan Thornburg
cRTI International, Research Triangle Park, NC
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elizabeth A. Secor
aCenter for Genes, Environment, and Health, National Jewish Health, Denver, CO
MA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Katharine L. Hamlington
dSection of Pediatric Pulmonary and Sleep Medicine, Children’s Hospital Colorado, Aurora, CO
eDepartment of Pediatrics, University of Colorado School of Medicine, Aurora, CO
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Allison M. Schiltz
dSection of Pediatric Pulmonary and Sleep Medicine, Children’s Hospital Colorado, Aurora, CO
eDepartment of Pediatrics, University of Colorado School of Medicine, Aurora, CO
BA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kristy L. Freeman
dSection of Pediatric Pulmonary and Sleep Medicine, Children’s Hospital Colorado, Aurora, CO
eDepartment of Pediatrics, University of Colorado School of Medicine, Aurora, CO
MBS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jamie L. Everman
aCenter for Genes, Environment, and Health, National Jewish Health, Denver, CO
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tasha E. Fingerlin
aCenter for Genes, Environment, and Health, National Jewish Health, Denver, CO
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrew H. Liu
dSection of Pediatric Pulmonary and Sleep Medicine, Children’s Hospital Colorado, Aurora, CO
eDepartment of Pediatrics, University of Colorado School of Medicine, Aurora, CO
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Max A. Seibold
aCenter for Genes, Environment, and Health, National Jewish Health, Denver, CO
fDepartment of Pediatrics, National Jewish Health, Denver, CO 80206, USA
gDivision of Pulmonary Sciences and Critical Care Medicine, Department of Medicine, University of Colorado-AMC, Aurora, CO
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Background Indoor and outdoor air pollution levels are associated with poor asthma outcomes in children. However, few studies have evaluated whether breathing zone pollutant levels associate with asthma outcomes.

Objective Determine breathing zone exposure levels of NO2, O3, total PM10 and PM10 constituents among children with exacerbation-prone asthma, and examine correspondence with in-home and community measurements and associations with outcomes.

Methods We assessed children’s personal breathing zone exposures using wearable monitors. Personal exposures were compared to in-home and community measurements and tested for association with lung function, asthma control, and asthma exacerbations.

Results 81 children completed 219 monitoring sessions. Correlations between personal and community levels of PM10, NO2, and O3 were poor, whereas personal PM10 and NO2 levels correlated with in-home measurements. However, in-home monitoring underdetected brown carbon (Personal:79%, Home:36.8%) and ETS (Personal:83.7%, Home:4.1%) personal exposures, and detected black carbon in participants without these personal exposures (Personal: 26.5%, Home: 96%). Personal exposures were not associated with lung function or asthma control. Children experiencing an asthma exacerbation within 60 days of personal exposure monitoring had 1.98, 2.21 and 2.04 times higher brown carbon (p<0.001), ETS (p=0.007), and endotoxin (p=0.012), respectively. These outcomes were not associated with community or in-home exposure levels.

Conclusions Monitoring pollutant levels in the breathing zone is essential to understand how exposures influence asthma outcomes, as agreement between personal and in-home monitors is limited. Inhaled exposure to PM10 constituents modifies asthma exacerbation risk, suggesting efforts to limit these exposures among high-risk children may decrease their asthma burden.

CLINICAL IMPLICATIONS In-home and community monitoring of environmental pollutants may underestimate personal exposures. Levels of inhaled exposure to PM10 constituents appear to strongly influence asthma exacerbation risk. Therefore, efforts should be made to mitigate these exposures.

CAPSULE SUMMARY Leveraging wearable, breathing-zone monitors, we show exposures to inhaled pollutants are poorly proxied by in-home and community monitors, among children with exacerbation-prone asthma. Inhaled exposure to multiple PM10 constituents is associated with asthma exacerbation risk.

Competing Interest Statement

Camille M. Moore, Elizabeth A. Secor, Allison M. Schlitz, Kristy L. Freeman, Jamie L. Everman and Tasha E. Fingerlin have no financial disclosures or conflicts of interest to report. Jonathan Thornburg serves as the treasurer for the International Society of Exposure Science. Andrew H. Liu has received grants paid to Children's Hospital Colorado from ResMed and OM Pharma, consulting fees paid to the University of Colorado from ThermoFisher Scientific, and research equipment from ResMed/Propeller Health and Revenio. Andrew H. Liu has also served on data safety monitoring boards for AstraZeneca. Max A. Seibold received an honorarium for lecturing at the Colorado Allergy and Asthma Society.

Funding Statement

ENIGMA was funded by the National Heart, Lung and Blood Institute, National Institutes of Health, grant number 5P01HL132821.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The Colorado Multiple Institutional Review Board gave ethical approval for this work.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

Data Availability

All data produced in the present study are available upon reasonable request to the authors

  • ABBREVIATIONS

    ACT
    Asthma Control Test
    BC
    black carbon
    BrC
    brown carbon
    cACT
    Childhood ACT
    CASI
    Composite Asthma Severity Index
    EP
    exacerbation-prone
    ETS
    environmental tobacco smoke
    FDR
    false discovery rate
    IQR
    interquartile range
    LOD
    limit of detection
    NO2
    nitrogen dioxide
    O3
    ozone
    PM10
    particulate matter less than 10 microns in diameter
    PM2.5
    particulate matter less than 2.5 microns in diameter
    ppb
    parts per billion
  • Copyright 
    The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
    Back to top
    PreviousNext
    Posted September 23, 2023.
    Download PDF

    Supplementary Material

    Data/Code
    Email

    Thank you for your interest in spreading the word about medRxiv.

    NOTE: Your email address is requested solely to identify you as the sender of this article.

    Enter multiple addresses on separate lines or separate them with commas.
    Breathing zone pollutant levels are associated with asthma exacerbations in high-risk children
    (Your Name) has forwarded a page to you from medRxiv
    (Your Name) thought you would like to see this page from the medRxiv website.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Share
    Breathing zone pollutant levels are associated with asthma exacerbations in high-risk children
    Camille M. Moore, Jonathan Thornburg, Elizabeth A. Secor, Katharine L. Hamlington, Allison M. Schiltz, Kristy L. Freeman, Jamie L. Everman, Tasha E. Fingerlin, Andrew H. Liu, Max A. Seibold
    medRxiv 2023.09.22.23295971; doi: https://doi.org/10.1101/2023.09.22.23295971
    Twitter logo Facebook logo LinkedIn logo Mendeley logo
    Citation Tools
    Breathing zone pollutant levels are associated with asthma exacerbations in high-risk children
    Camille M. Moore, Jonathan Thornburg, Elizabeth A. Secor, Katharine L. Hamlington, Allison M. Schiltz, Kristy L. Freeman, Jamie L. Everman, Tasha E. Fingerlin, Andrew H. Liu, Max A. Seibold
    medRxiv 2023.09.22.23295971; doi: https://doi.org/10.1101/2023.09.22.23295971

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Subject Area

    • Epidemiology
    Subject Areas
    All Articles
    • Addiction Medicine (349)
    • Allergy and Immunology (668)
    • Allergy and Immunology (668)
    • Anesthesia (181)
    • Cardiovascular Medicine (2648)
    • Dentistry and Oral Medicine (316)
    • Dermatology (223)
    • Emergency Medicine (399)
    • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
    • Epidemiology (12228)
    • Forensic Medicine (10)
    • Gastroenterology (759)
    • Genetic and Genomic Medicine (4103)
    • Geriatric Medicine (387)
    • Health Economics (680)
    • Health Informatics (2657)
    • Health Policy (1005)
    • Health Systems and Quality Improvement (985)
    • Hematology (363)
    • HIV/AIDS (851)
    • Infectious Diseases (except HIV/AIDS) (13695)
    • Intensive Care and Critical Care Medicine (797)
    • Medical Education (399)
    • Medical Ethics (109)
    • Nephrology (436)
    • Neurology (3882)
    • Nursing (209)
    • Nutrition (577)
    • Obstetrics and Gynecology (739)
    • Occupational and Environmental Health (695)
    • Oncology (2030)
    • Ophthalmology (585)
    • Orthopedics (240)
    • Otolaryngology (306)
    • Pain Medicine (250)
    • Palliative Medicine (75)
    • Pathology (473)
    • Pediatrics (1115)
    • Pharmacology and Therapeutics (466)
    • Primary Care Research (452)
    • Psychiatry and Clinical Psychology (3432)
    • Public and Global Health (6527)
    • Radiology and Imaging (1403)
    • Rehabilitation Medicine and Physical Therapy (814)
    • Respiratory Medicine (871)
    • Rheumatology (409)
    • Sexual and Reproductive Health (410)
    • Sports Medicine (342)
    • Surgery (448)
    • Toxicology (53)
    • Transplantation (185)
    • Urology (165)